Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Diabet Med ; 41(9): e15326, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38890775

ABSTRACT

AIMS: The direct cost of diabetes to the UK health system was estimated at around £10 billion in 2012. This analysis updates that estimate using more recent and accurate data sources. METHODS: A pragmatic review of relevant data sources for UK nations was conducted, including population-level data sets and published literature, to generate estimates of costs separately for Type 1, Type 2 and gestational diabetes. A comprehensive cost framework, developed in collaboration with experts, was used to create a population-based cost of illness model. The key driver of the analysis was prevalence of diabetes and its complications. Estimates were made of the excess costs of diagnosis, treatment and diabetes-related complications compared with the general UK population. Estimates of the indirect costs of diabetes focused on productivity losses due to absenteeism and premature mortality. RESULTS: The direct costs of diabetes in 2021/22 for the UK were estimated at £10.7 billion, of which just over 40% related to diagnosis and treatment, with the rest relating to the excess costs of complications. Indirect costs were estimated at £3.3 billion. CONCLUSIONS: Diabetes remains a considerable cost burden in the UK, and the majority of those costs are still spent on potentially preventable complications. Although rates of some complications are reducing, prevalence continues to increase and effective approaches to primary and secondary prevention continue to be needed. Improvements in data capture, data quality and reporting, and further research on the human and financial implications of increasing incidence of Type 2 diabetes in younger people are recommended.


Subject(s)
Cost of Illness , Diabetes Mellitus, Type 1 , Diabetes Mellitus, Type 2 , Health Care Costs , Humans , United Kingdom/epidemiology , Diabetes Mellitus, Type 2/economics , Diabetes Mellitus, Type 2/epidemiology , Female , Health Care Costs/statistics & numerical data , Pregnancy , Diabetes Mellitus, Type 1/economics , Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 1/therapy , Prevalence , Diabetes, Gestational/economics , Diabetes, Gestational/epidemiology , Diabetes, Gestational/therapy , Diabetes Complications/economics , Diabetes Complications/epidemiology , Models, Economic , Absenteeism , Mortality, Premature
2.
Mar Pollut Bull ; 74(1): 82-94, 2013 Sep 15.
Article in English | MEDLINE | ID: mdl-23948091

ABSTRACT

Water turbidity and suspended sediment concentration (SSC) are commonly used as part of marine monitoring and water quality plans. Current management plans utilise threshold SSC values derived from mean-annual turbidity concentrations. Little published work documents typical ranges of turbidity for reefs within open coastal waters. Here, time-series turbidity measurements from 61 sites in the Great Barrier Reef (GBR) and Moreton Bay, Australia, are presented as turbidity exceedance curves and derivatives. This contributes to the understanding of turbidity and SSC in the context of environmental management in open-coastal reef environments. Exceedance results indicate strong spatial and temporal variability in water turbidity across inter/intraregional scales. The highest turbidity across 61 sites, at 50% exceedance (T50) is 15.3 NTU and at 90% exceedance (T90) 4.1 NTU. Mean/median turbidity comparisons show strong differences between the two, consistent with a strongly skewed turbidity regime. Results may contribute towards promoting refinement of water quality management protocols.


Subject(s)
Conservation of Natural Resources/methods , Coral Reefs , Water Pollution/prevention & control , Australia , Environmental Monitoring , Seawater/chemistry , Water Pollution/analysis
SELECTION OF CITATIONS
SEARCH DETAIL